Radium-223 vs EBRT for multiple painful bone metastases: the data favor radium-223.
Nicholas J
NJ
Vogelzang
D001859:Bone Neoplasms / Q000532:radiotherapy* / Q000556:secondary*; D019583:Dose Fractionation, Radiation; D006801:Humans; D008297:Male; D059408:Pain Management / Q000379:methods; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000532:radiotherapy*; D019275:Radiopharmaceuticals / Q000009:adverse effects / Q000627:therapeutic use*; D011878:Radiotherapy / Q000009:adverse effects / Q000191:economics / Q000379:methods; D011883:Radium / Q000009:adverse effects / Q000627:therapeutic use*; D018570:Risk Assessment
D019275:Radiopharmaceuticals; D011883:Radium